Manulife Financial (TSX:MFC) Signs $3.2 Billion Long Term Care Reinsurance Deal
Bailey Pemberton
Sun, 9 August 2026 at 4:41 am GMT+5:30
3 min read
- MFC
-0.58% - MUV2.DE
-1.38% - MFC
-0.58%
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide
Manulife Financial (TSX:MFC) announced a C$3.2b long term care reinsurance agreement with Munich Re alongside its latest results
The transaction relates to Manulife’s long term care insurance block and is intended to transfer a portion of related risk to Munich Re
Manulife reported 16% growth in core earnings in the same update, highlighting the financial impact of recent actions
Manulife is far from the only insurer reshaping its risk profile, so it can be useful to compare this move with other companies that focus on capital strength and earnings resilience through 9 resilient stocks with low risk scores
Manulife Financial sits among the largest life insurers on the TSX, with the stock trading at about CA$61.78 and showing very strong long term price appreciation over the past five years. The share price is up 24.1% year to date and 55.1% over the past year, although it has edged down 0.8% over the past week, which gives investors a sense of how the market has recently been reassessing the story
We’ve flagged 1 risk for Manulife Financial. See which could impact your investment
What this long term care deal really says about the Manulife Financial Narrative
The core idea behind the Manulife Financial investment story is that the company is trying to tilt its business mix toward capital-light, fee-oriented growth while cleaning up legacy blocks that can unsettle earnings. This long term care reinsurance deal fits directly into that premise
“Manulife’s disciplined capital management, evidenced by a robust balance sheet, ongoing share buybacks, and reallocation toward higher-growth, more profitable business lines, enhances financial flexibility and capital returns…”
Read the full Manulife Financial narrativeto see the case behind these numbers
The C$3.2b long term care reinsurance agreement looks like an execution step on the narrative that Manulife wants less earnings noise from older U.S. blocks and more room to lean into Asia, U.S. protection and wealth businesses. It ties directly to the goal of reallocating capital from legacy segments that analysts already flagged as vulnerable to reserve and regulatory shocks
At the same time, 16% growth in core earnings and ongoing dividends and buybacks show that capital return remains central to the story, not just capital clean up. The risk is that investors focus only on the headline earnings strength and underplay the execution challenge of managing reinsurance, regulatory approvals and the remaining legacy exposure, while peers like Sun Life and Great-West Lifeco are also active in de-risking moves
